Liz joins Juvo Ventures as Associate from Proteostasis Therapeutics (PTI), where she served as the Director of Commercial Strategy and Business Development. At PTI, Liz focused on strategic partnerships, helped secure an $80M follow-on raise from institutional investors, and led a team that implemented an outcomes-based and personalized medicine approach to help bring PTI’s Cystic Fibrosis (CF) drug to market. Liz reimagined the traditional drug pricing model to provide more equitable access to CF drugs and championed a value-based reimbursement model.

Prior to joining PTI, Liz served as the Senior Associate of Corporate Development at Decision Resources Group, one of the top global providers of analytics and insights in the healthcare industry. She served as an investment banker at MTS Health Partners where she worked on mergers and acquisitions and private placements in the life sciences industry. Liz began her career at J.P. Morgan, where she was part of the selective Thomas G. Labrecque Smart Start internship program for 4 years and worked on IPOs in the technology, media, & telecom and oil & gas industries during her Equity Capital Markets rotation.

Liz holds a bachelor’s degree in Financial Economics with an additional focus in Political Science, from Columbia University. She is a first-generation American that speaks English and Russian fluently and has lived in New York City, Turkey, and Boston. Liz now resides in New York City.